IPXL
Impax Laboratories, Inc.
IPXL
IPXL
Delisted
IPXL was delisted on the 4th of May, 2018.
162 hedge funds and large institutions have $1.42B invested in Impax Laboratories, Inc. in 2014 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 53 increasing their positions, 74 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
56% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 39
Holders
162
Holding in Top 10
–
Calls
$20.9M
Puts
$2.29M
Top Buyers
| 1 | +$55.2M | |
| 2 | +$23.5M | |
| 3 | +$16M | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$15.3M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$9.07M |
Top Sellers
| 1 | -$38.2M | |
| 2 | -$35.1M | |
| 3 | -$21M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$16M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$14.2M |